The Journal of clinical endocrinology and metabolism
Metabolic effects of testosterone therapy in transgender and gender diverse individuals with polycystic ovary syndrome.
Justine Herndon, J Anderson McNeil, Salym Winter, Alice Y Chang
Published: 202610.1210/clinem/dgag032
Abstract
BACKGROUND: Polycystic ovary syndrome (PCOS) affects 10 to 13% of individuals assigned female at birth (AFAB), although a greater prevalence is reported in transgender/gender diverse individuals (TGD) (23.8%-38.8%). Testosterone therapy (TT) in TGD i…
Preview only. Read the full abstract at the source